Therapeutic cannabis use in 2018: where do we stand?

Published by Michael on

bidmc.harvard.edu.2New York Medical College, Valhalla, NY, USA.3Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Addictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.PMID: 30686389 DOI: 10.1016/S2215-0366(18)30417-6 Share Supplemental Content —

View the Original article

Partage le savoir
Categories: Medical
Tags:

Related Posts

Medical

Measuring Impaired Control over Cannabis Use: Initial Evaluation of the Impaired Control Scale-Cannabis (ICS-C)

Subst Use Misuse. 2022 May 27:1-10. doi: 10.1080/10826084.2022.2079137. Online ahead of print. ABSTRACT Background: Impaired control is a central concept in addiction. Impaired control over alcohol has been associated with heavy drinking and alcohol-related problems Read more…

Medical

Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study

Arch Oral Biol. 2022 May 19;140:105464. doi: 10.1016/j.archoralbio.2022.105464. Online ahead of print. ABSTRACT OBJECTIVE: To evaluate the anti-inflammatory and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol (CBD). DESIGN: Read more…

Medical

Cannabis and road traffic accidents in South East Asia region: Let there be light

Asian J Psychiatr. 2022 May 13;73:103173. doi: 10.1016/j.ajp.2022.103173. Online ahead of print. NO ABSTRACT PMID:35623272 | DOI:10.1016/j.ajp.2022.103173 Source: ncbi 2 Partage le savoir

error: Content is protected !!